Insulet CorporationPODD
NasdaqGS•Healthcare•Medical Devices
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $2.90B, growing 31.9% year-over-year. TTM net income stood at $302.80M (24.7% contraction). Quarterly EBITDA was $148.30M and operating income was $122.10M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze PODD growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters